Search Within

Hematologic Malignancies, Division of

Formats
  1. Meeting Abstract (6372)
  2. Journal Article (5780)
  3. Review (420)
  4. Editorial (194)
  5. Book Section (188)
  6. Research Letter (179)
  7. Guidelines (88)
  8. Conference Paper (65)
  9. Correspondence (62)
  10. Miscellaneous (18)
  11. Book Whole (9)
Groups
  1. Department of Medicine (13274)
  2. Center for Hematologic Malignancies (10609)
  3. GSK Faculty (4481)
  4. Adult Leukemia (3672)
  5. Bone Marrow Transplant (2848)
  6. Lymphoma (2704)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (943)
  3. Ross Levine (787)
  4. Andrew Zelenetz (784)
  5. Steven Horwitz (669)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (336)
  2. 2024 (823)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3529)
  2. Journal of Clinical Oncology (1233)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (329)
  5. Haematologica (291)
  6. Bone Marrow Transplantation (239)

More Publications

Publishers
  1. American Society of Hematology (3806)
  2. Elsevier Inc. (1529)
  3. American Society of Clinical Oncology (1288)
  4. Nature Publishing Group (1009)
  5. American Association for Cancer Research (641)
  6. Wiley Blackwell (433)

More Publishers

Results (13375)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 2 study to evaluate the efficacy and safety of selinexor monotherapy in patients with JAK inhibitor-naive myelofibrosis and moderate thrombocytopenia (XPORT-MF-044)
    Meeting Abstract

    Scandura, J. M.; Gerds, A. T.; Ritchie, E. K.; Wang, X.; Kye, S.; Rampal, R. K.
    Blood (2023)

    Fulltext@MSK | Save
  • Ivosidenib for patients with clonal cytopenia of undetermined significance and mutations in IDH1
    Meeting Abstract

    Petrone, G.; Stein, E. M.; Bolton, K. L.
    Blood (2023)

    Fulltext@MSK | Save
  • Molecular monitoring with tumor DNA and nivolumab maintenance: A pilot study in diffuse large B-cell lymphoma
    Meeting Abstract

    Nakhoda, S.; Sklarz, T.; Pagan, C.; Matasar, M.; Messmer, M.; Frosch, Z. A. K.; Wang, Y. L.; Yanovsky, A. V.; Khanal, R.; Tan, C. R.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Multi-cancer early detection test is sensitive and accurate in detecting shared DNA methylation signal in a variety of lymphoid and plasma cell neoplasms
    Meeting Abstract

    Westgate, C.; Salles, G.; Shih, S.; Lopatin, M.; Kurtzman, K. N.; Kappes, K.; Venn, O.; Parekh, S.; Venstrom, J. M.; Younes, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Potent and target specific cytotoxicity of PRAME TCR mimic CAR T cells in KMT2A-rearranged AML patient-derived xenograft model
    Meeting Abstract

    Kirkey, D. C.; Robinson, L.; Hylkema, T.; Loeb, A.; Ries, R. E.; McKay, C.; Root, C.; Pardo, L.; Loeb, K. R.; Le, Q.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • An updated comparison of clinical outcomes from 4-year follow-up of ZUMA-5 (axicabtagene ciloleucel) and the international scholar-5 external control cohort in relapsed/refractory follicular lymphoma
    Meeting Abstract

    Gribben, J. G.; Ghione, P.; Palomba, M. L.; Ray, M. D.; Limbrick-Oldfield, E. H.; Kanters, S.; Bobillo, S.; Ribiero, M. T.; Jacobson, C. A.; Neelapu, S. S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase 1b trial of DISC-0974, an anti-hemojuvelin antibody, in patients with myelofibrosis and anemia
    Meeting Abstract

    Gangat, N.; Foran, J. M.; Halpern, A. B.; Rampal, R. K.; Novikov, N.; Buch, A.; Pelletier, O.; Savage, W.; Tefferi, A.
    Blood (2023)

    Fulltext@MSK | Save
  • Impact of symptom benefit and transfusion response on survival in myelofibrosis patients treated with pacritinib: PERSIST-2 landmark survival analysis
    Meeting Abstract

    Ajufo, H.; Bewersdorf, J. P.; Harrison, C. N.; Palandri, F.; Mascarenhas, J.; Palmer, J.; Gerds, A. T.; Kiladjian, J. J.; Buckley, S.; Derkach, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • PRC2-mediated apoptosis evasion is a therapeutic target of MDS/AML harboring inv(3)/t(3;3) and-7
    Meeting Abstract

    Kunimoto, H.; Miura, A.; Sagisaka, M.; Ito, M.; Honma, D.; Tsutsumi, S.; Sakuma, T.; Ohashi, T.; Teranaka, H.; Ikeda, J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Preliminary safety results of the open-label phase of a 2-part phase 1b study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of an investigational microbiome therapeutic, SER-155, in adults undergoing hematopoietic cell transplantation
    Meeting Abstract

    Ponce, D. M.; Kosuri, S.; Khera, N.; Defilipp, Z.; Lichter, D. I.; Peled, J. U.; van den Brink, M. R. M.; Brady, K.; Puhl, M. D.; Glick, G.; more...
    Blood (2023)

    Fulltext@MSK | Save